Phibro Animal Health PAHC
NASDAQ PAHC
$35.02 -0.95 (-2.64%)
At close: Nov 16, 2026 · 4:00 PM EST

Phibro Animal Health (PAHC) Total Non-Current Liabilities (2013 - 2026)

Updated

Phibro Animal Health (PAHC) recorded Total Non-Current Liabilities of $1.01 billion in fiscal Q1 2027 (quarter ended Sep 30, 2026), up 1.1% from $994.66 million a year earlier but down 1.8% from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

At the end of FY2026 (ended Jun 30, 2026), Phibro Animal Health reported Total Non-Current Liabilities of $1.02 billion, up 2.8% from FY2025.

  • Annual Total Non-Current Liabilities has increased for nine straight fiscal years, with a five-year compound annual growth rate of 13.4% (FY2021 to FY2026).
  • Across earlier fiscal years, Total Non-Current Liabilities came in at $995.91 million in FY2025 (+50.3%), $662.44 million in FY2024 (+5.4%), $628.54 million in FY2023 (+3.2%) and $608.76 million in FY2022 (+11.3%).
  • Quarterly Total Non-Current Liabilities has ranged from $553.95 million in fiscal Q2 2022 to $1.02 billion in fiscal Q4 2026 over the past five years.
  • On a year-over-year basis, Total Non-Current Liabilities has increased for 32 consecutive quarters, with growth averaging 27.1% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Total Non-Current Liabilities ranged from 1.1% (fiscal Q1 2024) to 54.6% (fiscal Q1 2026).
  • Per Business Quant, the preceding three fiscal quarters came in at $1.02 billion (Q4 2026), $994.56 million (Q3 2026) and $992.97 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 102.65 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 117.60 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -36.84 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 36.05 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 96.04 Bn
10 Phibro Animal Health 1.42 Bn 1.11 Bn 128.54 Mn 1.01 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.01 Bn
Jun 30, 2026 1.02 Bn
Mar 31, 2026 994.56 Mn
Dec 31, 2025 992.97 Mn
Sep 30, 2025 994.66 Mn
Jun 30, 2025 995.91 Mn
Mar 31, 2025 977.64 Mn
Dec 31, 2024 970.13 Mn
Sep 30, 2024 643.56 Mn
Jun 30, 2024 662.44 Mn
Mar 31, 2024 645.08 Mn
Dec 31, 2023 636.59 Mn
Sep 30, 2023 631.07 Mn
Jun 30, 2023 628.54 Mn
Mar 31, 2023 631.32 Mn
Dec 31, 2022 628.38 Mn
Sep 30, 2022 624.24 Mn
Jun 30, 2022 608.76 Mn
Mar 31, 2022 587.72 Mn
Dec 31, 2021 553.95 Mn
API Access

Phibro Animal Health Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PAHC&period=max&api_key=YOUR_API_KEY